Forbes

In this week’s edition of InnovationRx, we look at the AI drug discovery startup Lilly and Pfizer are betting on, the greatest living immigrants in healthcare and more.

Primary care physician compensation reached nearly $330,000 last year but “increases generally trailed the cost of living,” the Medical Group Management Association said.

AI is helping hospitals improve diagnostics and patient care, but it's also giving cybercriminals new tools to target healthcare systems.

An ER doc's guide to the biggest health risks at the 2026 FIFA World Cup. 4 tips on heat, alcohol, vaccines, and how to stay safe across 16 cities this summer.

The Code as Witness written by Steven C. Quay is part scientific investigation, part policy strategy, and part warning about the future of biological research.

How does Medicare approve technology for new patients? What is the alternative NTAP or New Technology Add-on Payment Pathway? And why does Medicare want to repeal it?

Half of U.S. employers and health plans are balking at paying for GLP-1 drugs like Ozempic, Zepbound and Wegovy for weight loss and obesity treatment, a new report shows.

For 14 years, patient access to TAVR has been restricted for Medicare beneficiaries under a Coverage with Evidence Development requirement. This could change by June 15.

The U.S. Ebola response has been reactionary as opposed to proactive. A doctor breaks down why and how it mirrors the U.S. response to COVID-19.

Summer break can disrupt routines, increase anxiety, loneliness, and screen time, creating unexpected mental health challenges for children and parents.

Data from Eventbrite showed a 567 percent increase in phone-free events around the world from 2024 to 2025. Here are some of the trends that may be driving this rise.,

The death rate in the group treated with daraxonrasib was 60% lower than those on chemotherapy. This is hailed as a major advance against metastatic pancreatic cancer.

Generative AI could save lives by improving chronic disease care, after-hours guidance and clinical decision-making — if medicine moves faster.

The American Medical Association will launch a national campaign called “Have You asked your Doctor?” to combat health misinformation and “rebuild trust in medicine.”